Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yafei Su
Observed names:
Y Su,
Y. Su,
苏雅妃
Institutions:
Fuzhou Second Hospital,
University at Buffalo, State University of New York
Observed institutions:
State University of New York,
Xiamen University,
Tianjin Medical University Cancer Institute and Hospital,
Fuzhou Second Hospital,
Tianjin Medical University,
University at Buffalo, State University of New York
show all 6
ORCID:
0000-0001-6412-6559
Observed ORCID:
0000-0001-6412-6559
OpenAlex ID:
A5025065096
Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment
2023
·
Lingyue Yan
, Yafei Su
, et al.
·
Molecular Therapy — Nucleic Acids
·
53
PDF
Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers
2014
·
F. Xu
, H. Zhang
, et al.
·
Clinical & Translational Oncology
·
50
Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2024
·
Chang-Chieh Hsu
, Yafei Su
, et al.
·
Cancer Research Communications
·
13
A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer
2023
·
Tatiana Shaurova
, Lingyue Yan
, et al.
·
癌症：英文版
·
7
PDF
Lipid nanoparticles that co-deliver poly(I:C) and short peptide antigens elicit anti-tumor responses with vaccination
2025
·
Yuan Luo
, Qinzhe Li
, et al.
·
Biomaterials
·
6
Fuyuan decoction prevents nasopharyngeal carcinoma metastasis by inhibiting circulating tumor cells/ endothelial cells interplay and enhancing anti-cancer immune response
2024
·
Yuying Ye
, Mengting Lin
, et al.
·
Frontiers in Pharmacology
·
3
PDF
Biyuantong decoction improves chronic rhinosinusitis by inhibiting inflammatory cell adhesion via NF-кB pathway modulation
2025
·
Yuying Ye
, Yinyin Yao
, et al.
·
Journal of Ethnopharmacology
·
2
Correlation between transcription factor activator protein-2β (TFAP-2β) and endometrial carcinoma.
2015
·
P Cui
, K Shi
, et al.
·
PubMed
·
2
Exosomal Thomsen–Friedenreich Glycoantigen as a Sensitive and Specific Biomarker for Colon, Ovarian and Prostate Cancer Diagnosis
2025
·
Yafei Su
, Man Qi
, et al.
·
Cancers
·
1
Mitochondrial ncRNA LDL-805 declines in alveolar epithelial type 2 cells of chronic obstructive pulmonary disease patients
2024
·
Theodore L. Mathuram
, Yafei Su
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Abstract 2716: Further development of microRNA-34a therapeutics to target castration-resistant prostate cancer
2023
·
Wen (Jess) Li
, Xiaozhuo Liu
, et al.
·
Cancer Research
·
1
Table S2 from Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2025
·
Chang-Chieh Hsu
, Yafei Su
, et al.
Figure S2 from Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2025
·
Chang-Chieh Hsu
, Yafei Su
, et al.
Figure S1 from Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2025
·
Chang-Chieh Hsu
, Yafei Su
, et al.
Supplementary Figure S4 from Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2025
·
Chang-Chieh Hsu
, Yafei Su
, et al.
Figure S3 from Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2025
·
Chang-Chieh Hsu
, Yafei Su
, et al.
Table S1 from Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2025
·
Chang-Chieh Hsu
, Yafei Su
, et al.
Figure S1 from Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2024
·
Chang-Chieh Hsu
, Yafei Su
, et al.
PDF
Table S1 from Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2024
·
Chang-Chieh Hsu
, Yafei Su
, et al.
PDF
Table S2 from Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2024
·
Chang-Chieh Hsu
, Yafei Su
, et al.
Figure S3 from Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2024
·
Chang-Chieh Hsu
, Yafei Su
, et al.
Figure S2 from Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2024
·
Chang-Chieh Hsu
, Yafei Su
, et al.
Supplementary Figure S4 from Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2024
·
Chang-Chieh Hsu
, Yafei Su
, et al.
Figure S2 from Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2024
·
Chang-Chieh Hsu
, Yafei Su
, et al.
Figure S1 from Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses
2024
·
Chang-Chieh Hsu
, Yafei Su
, et al.
Show more works
View as search
Works count:
57
Citation count:
139
H-index:
5
I10-index:
3
Year
Topic
Type
